EODData

MEMBERSHIP REGISTER LOG IN

FRA, 2B30: XERIS BIOPH.HOL. DL-0001

31 Mar 2026
LAST:

4.822

CHANGE:
 0.21		OPEN:
4.822		HIGH:
4.822		ASK:
0.000		VOLUME:
0
CHG(%):
4.55		PREV:
4.612		LOW:
4.822		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
31 Mar 264.8224.8224.8224.8220
30 Mar 264.6124.6124.6124.6120
27 Mar 264.7484.7484.7484.7480
26 Mar 264.5064.5064.5064.506100
25 Mar 264.4824.4824.4824.482100
24 Mar 264.7584.7584.7584.758100
23 Mar 264.6404.6404.6404.640100
20 Mar 264.7624.7624.7624.762100
19 Mar 264.6664.8164.6664.8160
18 Mar 264.7944.9504.7944.9500

PROFILE

Name:XERIS BIOPH.HOL. DL-0001
About:Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Sector:Healthcare
Industry:Biotechnology
Address:1375 West Fulton Street, Chicago, IL, United States, 60607
Website:https://www.xerispharma.com
ISIN:US98422E1038

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-16.30 
Forward P/E:20.53 
PEG Ratio:0.25 
Price to Sales:3.76 
Price to Book:-1,146.12 
Profit Margin:-0.06 
Operating Margin:0.09 
Return on Assets:0.03 
Return on Equity:1.85 
Revenue:225.83M 
EBITDA:22.59M 
Shares:161.48M 
Market Cap:778.66M 

TECHNICAL INDICATORS

MA5:4.634.1%
MA10:4.712.4%
MA20:4.810.3%
MA50:5.4513.1%
MA100:5.9022.4%
MA200:5.8220.6%
STO9:100.00 
STO14:72.65
RSI14:47.11
WPR14:-27.35
MTM14:-0.07
ROC14:-0.01 
ATR:0.14 
Week High:4.820.0%
Week Low:4.487.6%
Month High:6.1226.9%
Month Low:4.4820.6%
Year High:8.4875.8%
Year Low:3.4041.7%